Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.31 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28071244 | 0.78 | CCNT1 (0.33) | CCNT1CDK9HASPIN | |
| SCHEMBL18341916 | 0.71 | ALDH1A1 (0.36) | KMT2AALDH1A1FKBP5MEN1KDM4E | |
| SCHEMBL25861866 | 0.69 | ALDH1A1 (0.44) | ALDH1A1FKBP5CYP3A4TSHR | |
| SCHEMBL6502793 | 0.69 | IDO1 (0.38) | ALDH1A1FKBP5TSHR | |
| SCHEMBL311677 | 0.69 | ALDH1A1 (0.34) | ALDH1A1FKBP5KDM4ENPSR1 | |
| SCHEMBL13725534 | 0.69 | KMT2A (0.33) | KMT2AALDH1A1FKBP5MEN1KDM4E | |
| SCHEMBL21713005 | 0.68 | CYP3A4 (0.39) | KMT2AALDH1A1KDM4EBLMNPSR1 | |
| SCHEMBL28202370 | 0.67 | ALDH1A1 (0.35) | KMT2AALDH1A1MEN1KDM4ECYP3A4 | |
| SCHEMBL30200923 | 0.65 | IDO1 (0.39) | KDM4EBLMNPSR1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL28274257 | 0.64 | HRH3 (0.33) | ALDH1A1FKBP5KDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115838370-A | EGFR inhibitor and preparation method and application thereof | 山东新时代药业有限公司 | 2023-03-24 | — | — | CN | disclosed |
| EP-0836613-B1 | WATER-SOLUBLE ADENOSINE KINASE INHIBITORS | METABASIS THERAPEUTICS INC (US) | 2005-05-25 | — | — | EP | disclosed |
| EP-0832092-B1 | ORALLY ACTIVE ADENOSINE KINASE INHIBITORS | METABASIS THERAPEUTICS INC (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-0836613-A1 | WATER-SOLUBLE ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1998-04-22 | — | — | EP | disclosed |
| EP-0832092-A1 | ORALLY ACTIVE ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040706-A1 | ORALLY ACTIVE ADENOSINE KINASE INHIBITORS | GENSIA-SICOR (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040707-A1 | WATER-SOLUBLE ADENOSINE KINASE INHIBITORS | GENSIA SICOR (US) | 1996-12-19 | — | — | WO | disclosed |